{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:48:59Z","timestamp":1792028939519,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Development Foundation, Hospital for Infectious Diseases in Warsaw"},{"name":"Gilead Sciences Poland"},{"name":"Abbvie Poland"},{"name":"GlaxoSmithKline Poland"},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s15010-018-1154-0","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T11:52:13Z","timestamp":1526903533000},"page":"533-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project"],"prefix":"10.1007","volume":"46","author":[{"given":"Justyna D.","family":"Kowalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Ankiersztejn-Bartczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,21]]},"reference":[{"key":"1154_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493\u2013505.","journal-title":"N Engl J Med"},{"key":"1154_CR2","doi-asserted-by":"publisher","first-page":"e0186131","DOI":"10.1371\/journal.pone.0186131","volume":"12","author":"JD Kowalska","year":"2017","unstructured":"Kowalska JD, Wojcik G, Rutkowski J, Ankiersztejn-Bartczak M, Siewaszewicz E. Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations\u2014a message for Central and Eastern Europe. PLoS One. 2017;12:e0186131.","journal-title":"PLoS One"},{"key":"1154_CR3","unstructured":"UN AIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/90-90-90_en_0.pdf Accessed 16 Nov 2016."},{"key":"1154_CR4","doi-asserted-by":"publisher","first-page":"21847","DOI":"10.7448\/IAS.20.1.21847","volume":"20","author":"M Parczewski","year":"2017","unstructured":"Parczewski M, Siwak E, Leszczyszyn-Pynka M, Cielniak I, Burkacka E, Pulik P, et al. Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics. J Int AIDS Soc. 2017;20:21847.","journal-title":"J Int AIDS Soc"},{"key":"1154_CR5","unstructured":"ECDC. Thematic report: HIV continuum of care. Available at: http:\/\/ecdc.europa.eu\/en\/publications\/publications\/dublin-declaration-continuum-of-care-2014.pdf . Accessed on 25 November 2016."},{"key":"1154_CR6","unstructured":"Consolidated Strategic Information Guidelines for HIV in the Health Sector. WHO May 2015. http:\/\/www.who.int\/hiv\/pub\/guidelines\/strategic-information-guidelines\/en Accessed 5 Nov 2015."},{"issue":"5","key":"1154_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/hiv.12436","volume":"18","author":"JD Kowalska","year":"2016","unstructured":"Kowalska JD, Oprea C, de Witt S, Pozniak A, Gokengin D, Youle M, et al. Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration\u2014a comprehensive meeting report. HIV Med. 2016;18(5):370\u20135.","journal-title":"HIV Med"},{"key":"1154_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/hiv.12175","volume":"16","author":"M Ankiersztejn-Bartczak","year":"2015","unstructured":"Ankiersztejn-Bartczak M, Firlag-Burkacka E, Czeszko-Paprocka H, Kubicka J, Cybula A, Horban A, et al. Factors responsible for incomplete linkage to care after HIV diagnosis: preliminary results from the Test and Keep in Care (TAK) project. HIV Med. 2015;16:88\u201394.","journal-title":"HIV Med"},{"key":"1154_CR9","doi-asserted-by":"publisher","first-page":"e0162739","DOI":"10.1371\/journal.pone.0162739","volume":"11","author":"JD Kowalska","year":"2016","unstructured":"Kowalska JD, Shepherd L, Ankiersztejn-Bartczak M, Cybula A, Czeszko-Paprocka H, Firlag-Burkacka E, et al. Poor linkage to care despite significant improvement in access to early cART in Central Poland\u2014data from Test and Keep in Care (TAK) Project. PLoS One. 2016;11:e0162739.","journal-title":"PLoS One"},{"key":"1154_CR10","unstructured":"Shepherd LA-BM., Cybula A, Czeszko-Paprocka H, Firl\u0105g-Burkacka E, Horban A, Mocroft A, Kowalska JD. Poor linkage to care despite significant improvement in access to early cART\u2014data from Test and Keep in Care (TAK) project. In: 15th European AIDS conference. Barcelona 21\u201324 October 2015. Abstr. Nr. PS 8\/4."},{"key":"1154_CR11","unstructured":"PTN AIDS. Zasady opieki nad osobami zaka\u017conymi HIV. 2016 http:\/\/www.ptnaids.pl\/pliki\/zalecenia_2016_uzupelnione.pdf . Accessed 23 Apr 2016"},{"issue":"10","key":"1154_CR12","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1007\/s10461-017-1831-5","volume":"21","author":"M Mirandola","year":"2017","unstructured":"Mirandola M, Gios L, Sherriff N, Pachankis J, Toskin I, Ferrer L, et al. Socio-demographic characteristics, sexual and test-seeking behaviours amongst men who have sex with both men and women: results from a bio-behavioural survey in 13 European cities. AIDS Behav. 2017;21(10):3013\u201325.","journal-title":"AIDS Behav"},{"key":"1154_CR13","unstructured":"UNAIDS. UNAIDS strategy 2016\u20132021: on the fast-track to end AIDS. 2015. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf . Accessed 23 Apr 2016."},{"key":"1154_CR14","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.2196\/publichealth.7334","volume":"3","author":"S Stahlman","year":"2017","unstructured":"Stahlman S, Hargreaves JR, Sprague L, Stangl AL, Baral SD. Measuring sexual behavior stigma to inform effective HIV prevention and treatment programs for key populations. JMIR Public Health Surveill. 2017;3:e23.","journal-title":"JMIR Public Health Surveill"},{"key":"1154_CR15","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1093\/cid\/ciq045","volume":"52","author":"KA Christopoulos","year":"2011","unstructured":"Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis. 2011;52:S214\u201322.","journal-title":"Clin Infect Dis"},{"key":"1154_CR16","unstructured":"The People Living with HIV Stigma Index (STIGMA Index) project. HIV-related stigma: late testing, late treatment. A cross analysis of findings from the people living with HIV Stigma Index in Estonia, Moldova, Poland, Turkey, and Ukraine. 2010. http:\/\/www.gnpplus.net\/images\/stories\/Rights_and_stigma\/2011_HIVStigma_Report_EN.pdf . Accessed 23 Nov 2013"},{"key":"1154_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/09540121.2015.1100702","volume":"28","author":"M Rosinska","year":"2016","unstructured":"Rosinska M, Simmons R, Marzec-Boguslawska A, Janiec J, Porter K. Relating HIV testing patterns in Poland to risky and protective behaviour. AIDS Care. 2016;28:423\u201331.","journal-title":"AIDS Care"},{"key":"1154_CR18","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/S2352-3018(15)00027-2","volume":"2","author":"JM Molina","year":"2015","unstructured":"Molina JM, Clotet B, van Lunzen J, Lazzarin A, Cavassini M, Henry K, et al. Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study. Lancet HIV. 2015;2:e127\u201336.","journal-title":"Lancet HIV"},{"key":"1154_CR19","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1016\/S2352-3018(16)30016-9","volume":"3","author":"K Squires","year":"2016","unstructured":"Squires K, Kityo C, Hodder S, Johnson M, Voronin E, Hagins D, et al. Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study. Lancet HIV. 2016;3:e410\u201320.","journal-title":"Lancet HIV"},{"key":"1154_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2016.8900","volume":"316","author":"HF Gunthard","year":"2016","unstructured":"Gunthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016;316:191\u2013210.","journal-title":"JAMA"},{"key":"1154_CR21","unstructured":"Proceedings of the 8th romanian national HIV\/AIDS congress and the 3rd Central European HIV forum: Sibiu, Romania. 5\u20137 May 2016. BMC Infect Dis. 2016;16 Suppl 3:290."},{"issue":"Suppl 3","key":"1154_CR22","first-page":"290","volume":"16","author":"E Adland","year":"2017","unstructured":"Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, et al. Differential Immunodominance Hierarchy of Cd8 + T Cell Responses in Hla-B*27:05 and B*27:02-Mediated Control of Hiv-1 Infection. J Virol. 2017;16(Suppl 3):290.","journal-title":"J Virol"},{"key":"1154_CR23","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1073\/pnas.050567397","volume":"97","author":"SA Migueles","year":"2000","unstructured":"Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA. 2000;97:2709\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1154_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/hiv.12306","volume":"17","author":"P Flandre","year":"2016","unstructured":"Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, et al. Comparative risk of failure of ABC\/3TC or TDF\/FTC based first-line regimens in patients with a high viral load. HIV Med. 2016;17:380\u20134.","journal-title":"HIV Med"},{"key":"1154_CR25","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10461-013-0656-0","volume":"18","author":"RH Remien","year":"2014","unstructured":"Remien RH, Dolezal C, Wagner GJ, Goggin K, Wilson IB, Gross R, et al. The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention. AIDS Behav. 2014;18:1541\u20137.","journal-title":"AIDS Behav"},{"key":"1154_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/jac\/dku372","volume":"70","author":"M Parczewski","year":"2015","unstructured":"Parczewski M, Leszczyszyn-Pynka M, Witak-Jedra M, Maciejewska K, Rymer W, Szymczak A, et al. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype. J Antimicrob Chemother. 2015;70:233\u201342.","journal-title":"J Antimicrob Chemother"},{"key":"1154_CR27","first-page":"29","volume":"61","author":"GP Stanczak","year":"2007","unstructured":"Stanczak GP, Stanczak JJ, Firlag-Burkacka E, Wiercinska-Drapalo A, Leszczyszyn-Pynkad M, Jablonowska E, et al. Transmission of HIV-1 drug resistance among newly diagnosed patients in Poland. Przegl Epidemiol. 2007;61:29\u201334.","journal-title":"Przegl Epidemiol"},{"key":"1154_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1097\/QAD.0000000000000171","volume":"28","author":"AN Phillips","year":"2014","unstructured":"Phillips AN, Munderi P, Revill PA, El-Sadr WM, Lundgren JD. Antiretroviral therapy recommendations for the global community: aspiration versus reality. AIDS. 2014;28:939\u201341.","journal-title":"AIDS"},{"key":"1154_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/hiv.12228","volume":"16","author":"N Geffen","year":"2015","unstructured":"Geffen N, Aagaard P, Corbelli GM, Meulbroek M, Peavy D, Rappoport C, et al. Community perspective on the INSIGHT strategic timing of antiretroviral treatment (START) trial. HIV Med. 2015;16:10\u20133.","journal-title":"HIV Med"},{"key":"1154_CR30","first-page":"1","volume":"16","author":"ISToATS Group","year":"2015","unstructured":"Group ISToATS, Lundgren J, Babiker A, Gordin F, Emery S, Fatkenheuer G, et al. Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Med. 2015;16:1\u20139.","journal-title":"HIV Med"},{"key":"1154_CR31","doi-asserted-by":"publisher","first-page":"e55312","DOI":"10.1371\/journal.pone.0055312","volume":"8","author":"AN Phillips","year":"2013","unstructured":"Phillips AN, Cambiano V, Nakagawa F, Brown AE, Lampe F, Rodger A, et al. Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic. PLoS One. 2013;8:e55312.","journal-title":"PLoS One"},{"key":"1154_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5114\/hivar.2017.68804","volume":"16","author":"JD Kowalska","year":"2017","unstructured":"Kowalska JD, Grzeszczuk A, Pyziak-Kowalska K, Marzec-Bogus\u0142awska A, Rosi\u0144ska M, Ankiersztejn-Bartczak M, Horban A. Shaping the HIV epidemic in Poland\u2014proceedings from the first Polish workshop on cascade of care in HIV. HIV AIDS Rev 2017;16:130\u20133.","journal-title":"HIV AIDS Rev"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-018-1154-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-018-1154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T04:13:20Z","timestamp":1571372000000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-018-1154-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,21]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s15010-018-1154-0","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,21]]},"assertion":[{"value":"24 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}